Calcineurin Inhibitors to Belatacept Switch Study to Prevent the Progression of Kidney Disease in Pancreas Transplant Alone Recipients
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2017
Price : $35 *
At a glance
- Drugs Belatacept (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 03 May 2017 Intermediate results presented at the 2017 American Transplant Congress.
- 04 May 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.